Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
European Cost of Asthma Treatment
- Status
- COMPLETED
- Phase
- N/A
Drug Use Investigation for ALLERMIST
- Status
- COMPLETED
- Phase
- N/A
Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet
- Status
- COMPLETED
- Phase
- N/A
Drug Use Investigation for LAMICTAL
- Status
- COMPLETED
- Phase
- N/A
Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse
- Status
- COMPLETED
- Phase
- PHASE2
Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)
- Status
- COMPLETED
- Phase
- N/A
Drug Use Investigation for IMIGRAN Tablet
- Status
- COMPLETED
- Phase
- N/A
Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)
- Status
- COMPLETED
- Phase
- N/A
BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance)
- Status
- COMPLETED
- Phase
- N/A
A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE2
GSK2239633 FTIH Study
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers
- Status
- COMPLETED
- Phase
- PHASE1
A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda
- Status
- COMPLETED
- Phase
- PHASE1
Korean Practice Patterns for Screening PCA(Prostate Cancer)
- Status
- COMPLETED
- Phase
- N/A
GSK1120212 Food-effect Study
- Status
- COMPLETED
- Phase
- PHASE1
Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)
- Status
- COMPLETED
- Phase
- N/A
Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)
- Status
- COMPLETED
- Phase
- N/A
Special Drug Use Investigation for PAXIL Tablet (Long-term)
- Status
- COMPLETED
- Phase
- N/A
Drug Use Investigation for PAXIL Tablet
- Status
- COMPLETED
- Phase
- N/A